Atlas Trials

Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant

Clinical trial NCT05982275 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05982275
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaAllogeneic Stem Cell Transplantation
Start date
2024-12-30
Primary completion
2029-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.